CONNECT WITH US
Tech

Tech

The Trump administration is now blacklisting this major biotech company and its affiliates. Here’s why

Fast Company logo

Published on

Add as a preferred source on Google
The Trump administration is now blacklisting this major biotech company and its affiliates. Here’s why

The Trump administration said Wednesday that it is blocking shipments by the Chinese biotech company BGI Group and its affiliates, alleging ties to forced labor in China’s far-west ethnic region of Xinjiang. S. Customs and Border Protection will bar goods by BGI Group, a major biotech company known for its genetic sequencing technologies, as well as BGI Genomics and MGI Tech. The Department of Homeland Security said the companies are either sourcing materials from Xinjiang or working with the regional government to “recruit, transport, transfer, harbor, or receive forced labor” of members of persecuted ethnic groups in Xinjiang, including Uyghurs. S. and China. S. investments in biotechnology, artificial intelligence and supercomputing from flowing into countries such as China. S. economic and trade relations, and violate the spirit of humanitarianism,” said China’s Ministry of Commerce in a Thursday morning statement. S. President Donald Trump in the southern Chinese city of Shenzhen, where BGI Group is based. Xi could then travel to Florida in December for the Group of 20 leaders summit and meet Trump for the fourth time this year as the two try to keep ties stable during a trade truce. ” The company has controlling stakes in BGI Genomics and MGI Tech, DHS said. S. S. national security and commercial interests. S. and has no access to Americans’ genetic data. While Congress failed to pass legislation banning BGI from doing business with federally funded medical providers, it passed a similar provision at the end of last year without naming specific companies.


Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.